Literature DB >> 18583002

Warfarin and intracranial haemorrhage.

Rebecca Appelboam1, Elfyn O Thomas.   

Abstract

SUMMARY: Spontaneous intracerebral haemorrhage is one of the most feared complications of long-term anticoagulation. Warfarin therapy not only increases the likelihood of suffering an intracranial haemorrhage, but also increases the mortality associated with it. This review aims to examine the incidence, pathogenesis, and outcome following a warfarin associated intracranial haemorrhage. It also evaluates the available evidence regarding optimal management of these patients, including timing and strategies for reversal of the coagulopathy, the role of neurocritical care and surgery, and indications for re-anticoagulation once the acute phase has past. The specific management of patients with prosthetic heart valves is also discussed. A summary of current societal guidelines is also included, as are some key practice points.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583002     DOI: 10.1016/j.blre.2008.05.001

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  12 in total

1.  Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage.

Authors:  Daniel Fischer; Jeffrey Sorensen; Gabriel V Fontaine
Journal:  Neurocrit Care       Date:  2018-02       Impact factor: 3.210

Review 2.  Management of bleeding in patients receiving conventional or new anticoagulants: a practical and case-based approach.

Authors:  Marco P Donadini; Walter Ageno; James D Douketis
Journal:  Drugs       Date:  2012-10-22       Impact factor: 9.546

3.  Prothrombin complex concentrate (Beriplex P/N).

Authors:  Lesley J Scott
Journal:  Drugs       Date:  2009-10-01       Impact factor: 9.546

4.  Use of Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal before Surgical Treatment of Intracranial Hemorrhage.

Authors:  Yun Wong
Journal:  Clin Med Insights Case Rep       Date:  2011-01-12

5.  Treatments for reversing warfarin anticoagulation in patients with acute intracranial hemorrhage: a structured literature review.

Authors:  Brett F Bechtel; Timothy C Nunez; Jennifer A Lyon; Bryan A Cotton; Tyler W Barrett
Journal:  Int J Emerg Med       Date:  2011-07-08

6.  Effect of complexation with arabinogalactan on pharmacokinetics of "guest" drugs in rats: for example, warfarin.

Authors:  Mikhail V Khvostov; Alexander A Chernonosov; Tatjana G Tolstikova; Marat F Kasakin; Olga S Fedorova; Alexander V Dushkin
Journal:  Biomed Res Int       Date:  2013-12-26       Impact factor: 3.411

7.  Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol.

Authors:  Anne Holbrook; Colin Dormuth; Richard Morrow; Agnes Lee; Sue Troyan; Guowei Li; Eleanor Pullenyegum
Journal:  BMJ Open       Date:  2016-11-24       Impact factor: 2.692

Review 8.  Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence.

Authors:  Caleb Ferguson; Sally C Inglis; Phillip J Newton; Sandy Middleton; Peter S Macdonald; Patricia M Davidson
Journal:  Vasc Health Risk Manag       Date:  2013-01-16

9.  Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case-control study.

Authors:  Chou Sherry H-Y; Cai Xuemei; Konigsberg Rachael G; Bresette Linda M; Henderson Galen V; Sorond Farzaneh A; Feske Steven K
Journal:  BMC Neurol       Date:  2012-12-15       Impact factor: 2.474

Review 10.  Management of anticoagulant-related intracranial hemorrhage: an evidence-based review.

Authors:  Bappaditya Ray; Salah G Keyrouz
Journal:  Crit Care       Date:  2014-05-23       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.